title: Muscle Fiber Conduction Velocity, Muscle Fiber Composition, and Power Performance.
abstract: The aim of this study was to explore the relationship between muscle fiber conduction velocity (MFCV), fiber type composition, and power performance in participants with different training background.
  
  
  
  Thirty-eight young males with different training background participated: sedentary (n = 10), endurance runners (n = 9), power trained (n = 10), and strength trained (n = 9). They performed maximal countermovement jumps (CMJ) and maximal isometric leg press for the measurement of the rate of force development (RFD). Resting vastus lateralis MFCV was measured with intramuscular microelectrodes on a different occasion, whereas muscle fiber type and cross-sectional area (CSA) of vastus lateralis were evaluated through muscle biopsies 1wk later.
  
  
  
  MFCV, CMJ power, RFD, and % CSA of type II and type IIx fibers were higher for the power-trained group (P < 0.001). No difference was found between sedentary participants and endurance runners in these variables, but both of these groups performed worse than strength/power participants. Close correlations were found between MFCV and fiber CSA as well as the % CSA of all fiber types as well as with RFD and CMJ power (r = 0.712-0.943, P < 0.005). Partial correlations revealed that the % CSA of IIx fibers dictates a large part of the correlation between MFCV and RFD, power performance. Significant models for the prediction of the % CSA of type IIa and type II as well as the CSA of all muscle fibers based upon MFCV, RFD, and CMJ were revealed (P = 0.000).
  
  
  
  MFCV is closely associated with muscle fiber % CSA. RFD and jumping power are associated with the propagation of the action potentials along the muscle fibers. This link is regulated by the size and the distribution of type II, and especially type IIx muscle fibers.
authors.affiliation: 1Athletics Laboratory, School of Physical Education and Sports Science, National and Kapodistrian University of Athens, Athens, GREECE; and 2Neurology Clinic, Aiginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, GREECE.
authors.forename: Spyridon
authors.initials: S
authors.lastname: Methenitis
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Karandreas
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Spengos
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Zaras
authors.forename: Angeliki-Nikoletta
authors.initials: AN
authors.lastname: Stasinaki
authors.forename: Gerasimos
authors.initials: G
authors.lastname: Terzis
mesh_terms: D000328:Adult; D056352:Athletes; D015444:Exercise / Q000502:physiology*; D005080:Exercise Test; D006801:Humans; D008297:Male; D018485:Muscle Fibers, Skeletal / Q000502:physiology*; D053580:Muscle Strength / Q000502:physiology*; D052097:Quadriceps Muscle / Q000502:physiology*; D057185:Sedentary Behavior; D055815:Young Adult